Kovack Advisors’s NEOPHOTONICS CORP NPTN Stock Holding History

Kovack Advisors’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-36,500	Closed	-$318K	–	778
2021 Q3	$318K	Buy	+36,500	New	+$333K	0.03%	507

Other funds holding NPTN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Kovack Advisors's NPTN Position: Q4 2021 in Review

Kovack Advisors sold out of NEOPHOTONICS CORP (NPTN) in Q4 2021, closing a stake of 36,500 shares — an estimated $318K sold.

Kovack Advisors first reported a position in NPTN in Q3 2021 and held it in 1 quarter. The position peaked at $318K in Q3 2021. 145 funds tracked by Wall St. Rank hold NPTN as of Q4 2021.

Kovack Advisors reported no remaining NEOPHOTONICS CORP position as of Q4 2021 after selling out during the quarter.
Kovack Advisors sold 36,500 NEOPHOTONICS CORP shares in Q4 2021, an estimated $318K.
Kovack Advisors first reported a position in NEOPHOTONICS CORP in Q3 2021 and held it in 1 quarter.
Kovack Advisors's NEOPHOTONICS CORP position peaked at $318K in Q3 2021.
145 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2021.

Based on Kovack Advisors's 13F filing for Q4 2021, filed 18 Jan 2022.